Nyxoah SA Revenue 2021-2025 | NYXH
Nyxoah SA revenue from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Nyxoah SA Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $5 |
| 2023 | $5 |
| 2022 | $3 |
| 2021 | $1 |
| 2020 | $0 |
| Nyxoah SA Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1 |
| 2024-12-31 | $1 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $2 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $0 |
| 2022-12-31 | $1 |
| 2022-09-30 | $0 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | |
| 2021-06-30 | |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.264B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.731B | 53.50 |
| Hims & Hers Health (HIMS) | United States | $11.944B | 124.09 |
| Tempus AI (TEM) | United States | $11.403B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.673B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.222B | 65.97 |
| Privia Health (PRVA) | United States | $2.843B | 194.33 |
| Enovis (ENOV) | United States | $1.910B | 10.65 |
| Clover Health Investments (CLOV) | United States | $1.634B | 0.00 |
| Schrodinger (SDGR) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.484B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.47 |
| Azenta (AZTA) | United States | $1.269B | 58.98 |
| 10x Genomics (TXG) | United States | $1.058B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.626B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.494B | 147.50 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.391B | 0.00 |
| TruBridge (TBRG) | United States | $0.361B | 801.00 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.32 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |